Table 4.
Antimicrobial and synergistic activity of the metabolite against pathogens Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes and Klebsiella pneumoniae.
| Clinical pathogens | Zone of inhibition (in mm) | Antibiotic [Chloramphenicol] A | Metabolite + Antibiotic Zone of inhibition (in mm) B |
Fold area increase (%) (B2−A2)/ A2 × 100 A-Antibiotic (ZOI) B-Antibiotic + metabolite |
|---|---|---|---|---|
| Escherichia coli | 10 mm | 32 | 33 | 6.34 |
| Staphylococcus aureus | 12 mm | 31 | 32 | 6.55 |
| Streptococcus pyogenes | >10 | 32 | 36 | 26.56 |
| Klebsiellapneumoniae | >10 | 31 | 32 | 6.55 |